Factors associated with improved outcome after surgery in metastatic breast cancer patients

American Journal of Surgery

Volumn 198, Issue 4, 2009, Pages 511-515

  McGuire, Kandace P ^a   Eisen, Sarah ^a   Rodriguez, Amilcar ^a   Meade, Tammi ^a   Cox, Charles E ^a   Khakpour, Nazanin ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Metastatic; Stage IV; Surgery

Indexed keywords

TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CONSERVATION THERAPY; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70349466660     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.06.011     Document Type: Article

References (15)

1. Khan S., Stewart A., and Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer?. Surgery 132 (2002) 620-627
2. Rao R., Feng L., Kuerer H., et al. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 6 (2008) 1696-1702
3. Gnerlich J., Jeffe D., Deshpane A., et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol 14 (2007) 2187-2194
4. Demicheli R., Valagussa P., and Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases?. Br J Cancer 85 (2001) 490-492
5. Retsky M., Bonadonna G., Demecheli R., et al. Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res 6 (2004) 372-374
6. Hormbrey E., Han C., Roberts A., et al. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res 9 (2003) 4332-4339
7. O'Reilly M., Holmgren L., Shing Y., et al. Angiostatin: a novel angiogenesis inhibitor that mediates suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
8. Fields R., Jeffe D., Trinkaus K., et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 14 (2007) 3345-3351
9. Flanigan R., Salmon S., Blumenstein B., et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345 (2001) 1655-1659
10. Dauplat J., Le Bouedec G., Pomel C., et al. Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol 19 (2000) 42-48
11. Martin R., Paty P., Fong Y., et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197 (2003) 233-241
12. Tanaka K., Shimada H., Matsuo K., et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136 (2004) 650-659
13. Doglietto G., Pacelli F., Caprino P., et al. Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg 65 (1999) 352-355
14. Danna E., Sinha P., Gilbert M., et al. Surgical removal of the primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 64 (2004) 2205-2211
15. Rastogi P., Andersen S.J., Bear H.D., et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26 (2008) 778-785